Submit or Track your Manuscript LOG-IN

Efficacy of Carica papaya Leaves Extract for Treating Thrombocytopenia: An In Silico and In Vivo Study in Rat Model

Efficacy of Carica papaya Leaves Extract for Treating Thrombocytopenia: An In Silico and In Vivo Study in Rat Model

Sony Eka Nugraha1*, Marianne Marianne2, Rony Abdi Syahputra2, Aji Najihudin3, Nikmatul Ikhrom Eka Jayani4, Shaum Shiyan5, Nabila Nabila6,7

1Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia; 2Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia; 3Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Garut University, West Java, Indonesia; 4Departement of Biology Pharmacy, Faculty of Pharmacy University of Surabaya, Surabaya, Indonesia; 5Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Universitas Sriwijaya, Indralaya, Sumatera Selatan, Indonesia; 6Faculty of Pharmacy, Institut Kesehatan Helvetia, Medan, Indonesia; 7Doctoral Program, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia.

 
*Correspondence | Sony Eka Nugraha, Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, Indonesia; Email: sonyekanugraha@usu.ac.id

Figure 1:

Gas chromatography/mass spectrometry (GC/MS) chromatograms 

Figure 2:

(A) Platelet concentration; (B) Bleeding Time; (C) Thrombopoietin concentration . Asterisk *P ≤ 0.05, **P ≤ 0.01, *** P ≤ 0.001, ****P ≤ 0.0001 represents significant differences to heparin group and NS represents not significant (P > 0.05).

Figure 3:

(A) Prothrombin time; (B) APTT. Asterisk *P ≤ 0.05, **P ≤ 0.01, *** P ≤ 0.001, ****P ≤ 0.0001 represents significant differences to heparin group and NS represents not significant (P > 0.05).

Figure 4:

Docking visualization. A, Rutin-TpoR; B, Carpaine -TpoR; C, Manghaslin-TpoR; D, Clitorin- TpoR.

Table 1:

Ligand name.

Advances in Animal and Veterinary Sciences

November

Vol. 12, Iss. 11, pp. 2062-2300

Featuring

Click here for more

Subscribe Today

Receive free updates on new articles, opportunities and benefits


Subscribe Unsubscribe